Latest pathological criteria for infective endocarditis
Reading File
Finding Sources
Searching PubMed
"infective endocarditis" AND "Duke criteria" AND pathological
Searching the Web
2023 2024 infective endocarditis Duke criteria pathological criteria updated ESC AHA guidelines
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC10681650
Reading File
I now have all the information needed for a comprehensive answer. Here is the full breakdown:
Pathological Criteria for Infective Endocarditis (IE)
The most current criteria are the 2023 Duke-ISCVID (International Society for Cardiovascular Infectious Diseases) Criteria, published in Clinical Infectious Diseases (Fowler et al., 2023 - PMC10681650). These supersede the Modified Duke Criteria (Li et al., 2000) and have been incorporated into the 2023 ESC Guidelines for Endocarditis.
DEFINITE ENDOCARDITIS - Pathological Criteria
A diagnosis of Definite IE is established by pathological criteria alone when ANY of the following are met from appropriate surgical or autopsy specimens:
Criterion 1 - Microorganism Identification
Microorganisms identified in the context of clinical signs of active endocarditis from:
- A vegetation
- Cardiac tissue
- An explanted prosthetic valve or sewing ring
- An ascending aortic graft (with concomitant evidence of valve involvement) (new in 2023)
- An endovascular intracardiac implantable electronic device (CIED) (new in 2023)
- An arterial embolus
Methods of identification now accepted (2023 update - key change):
- Culture
- Histologic examination (conventional staining)
- PCR (including 16S/18S rRNA gene PCR)
- Amplicon or metagenomic sequencing (new)
- In situ hybridization (including FISH/FISHseq) (new)
The 2023 criteria explicitly extended microorganism identification to include molecular/genetic techniques, which increased diagnostic yield by ~30% in prosthetic valve IE.
Criterion 2 - Histopathological Evidence of Active Endocarditis
Active endocarditis (may be acute or subacute/chronic) identified in or on:
- A vegetation
- Cardiac tissue
- An explanted prosthetic valve or sewing ring
- An ascending aortic graft (with concomitant evidence of valve involvement) (new in 2023)
- An endovascular CIED (new in 2023)
What constitutes "active endocarditis" histologically:
- Acute: neutrophilic infiltration, fibrinous material, necrosis, bacterial colonies
- Subacute/chronic: granulation tissue, mononuclear infiltrate, organizing thrombus, neovascularization
Comparison: Modified Duke (2000) vs. 2023 Duke-ISCVID Criteria
| Feature | Modified Duke (2000) | 2023 Duke-ISCVID |
|---|---|---|
| Microorganism ID methods | Culture + histology only | + PCR, metagenomic sequencing, in situ hybridization |
| Specimen sites | Vegetation, embolized vegetation, intracardiac abscess | + Cardiac tissue, explanted prosthetic valve/ring, ascending aortic graft, CIED |
| Active endocarditis confirmation | Histologic exam of vegetation/abscess | Expanded to same new specimen sites |
Overall Diagnostic Classification (2023 Duke-ISCVID)
| Category | Criteria |
|---|---|
| Definite | Pathologic criteria (either one above), OR 2 major clinical, OR 1 major + 3 minor, OR 5 minor |
| Possible | 1 major + 1 minor, OR 3 minor clinical criteria |
| Rejected | Firm alternate diagnosis (microbiologic or non-microbiologic) + no IE evidence; OR resolution within ≤4 days of antibiotics; OR no IE at surgery/autopsy after ≤4 days antibiotics |
Clinical Significance
The pathological criteria are the gold standard - when positive, clinical criteria become redundant and the diagnosis is definite. In practice, pathological criteria apply in:
- Patients undergoing valve surgery (explanted material available)
- Autopsy cases
- Embolic material retrieved surgically
The 2023 update is particularly important for culture-negative IE (10-30% of cases), where molecular techniques applied to tissue can now confirm the diagnosis pathologically even when blood cultures are negative.
Sources:
- 2023 Duke-ISCVID Criteria (Fowler et al., CID 2023) - the current standard
- Braunwald's Heart Disease, Table 80.3 (Modified Duke Criteria reference)
- 2023 ESC Guidelines for Management of Endocarditis
This is a shared conversation. Sign in to Orris to start your own chat.